A genetic result can sound more decisive than it is. For celiac disease, the most useful takeaway is asymmetrical: not having the associated HLA gene variants makes celiac disease very unlikely, while having them does not mean you have, or will develop, the condition. The test is best understood as a way to clarify risk or help resolve an uncertain workup, not as a stand-alone diagnosis.
What the genes actually show
Celiac disease is an immune reaction to gluten in people with particular genetic susceptibility. Tests look for HLA-DQ2 and HLA-DQ8 variants. These variants are common: NIDDK reports that about 30% of people have one of them, but only about 3% of carriers develop celiac disease. A positive result therefore identifies a necessary piece of the risk picture, not the disease itself.
A negative result is generally more useful. Without the usual HLA variants, celiac disease is very unlikely, and a clinician may use that finding to help rule it out when other test results are unclear. Rare exceptions and differences in what a particular assay tests mean results should be interpreted alongside the test’s report and a clinician’s advice.
A positive result is not a reason to stop eating gluten
Finding DQ2 or DQ8 does not confirm intestinal damage, explain symptoms, or predict when disease might appear. Many healthy people carry these variants. In my view, this is where genetic testing is often oversold: it can provide useful exclusion evidence, but a positive result can leave a person with more questions than answers.
Do not start a gluten-free diet just because a genetic test is positive, or before discussing diagnostic testing with a clinician. Avoiding gluten can affect standard test results. NIDDK explains that clinicians typically use celiac antibody blood tests and, when indicated, small-intestine biopsies; testing is most informative when the person is still eating gluten. A Celiac Disease Foundation explanation of consumer genetic tests likewise stresses that a gene test cannot diagnose the condition.
When the test may help, and what comes next
A clinician may consider HLA testing when previous antibody or biopsy results conflict, when someone has already stopped eating gluten and diagnosis is being reconsidered, or when family history raises questions about inherited risk. It can sometimes help decide whether further evaluation is worthwhile. It does not measure current inflammation, show whether gluten is causing symptoms, or replace antibody testing and biopsy when those are appropriate.
If you are considering a celiac genetic test, check which HLA variants the lab reports and ask how the result would change your next step. A positive result may lead to standard screening, especially if symptoms or a close family history are present; it is not a reason to self-diagnose. A negative result can be reassuring, but persistent symptoms still deserve medical evaluation for other causes. For a naturally gluten-free staple while you sort out testing, see Oceanup’s guide to what to know about rice.
The practical bottom line
Genetics can narrow the question, not answer all of it. Treat a positive result as susceptibility and a negative result as evidence that celiac disease is unlikely; let a clinician connect that information with symptoms, antibody results, diet, and any biopsy findings. In particular, do not use a gene result alone to begin lifelong gluten avoidance or to dismiss symptoms that need another explanation.
How this article was put together: This overview draws on current patient and clinician guidance from the U.S. National Institute of Diabetes and Digestive and Kidney Diseases and the Celiac Disease Foundation, reviewed in November 2026. Genetic tests can differ in what variants they report, so this article does not interpret an individual result or replace medical advice.
